China National Center For Cardiovascular Diseases
Clinical trials sponsored by China National Center For Cardiovascular Diseases, explained in plain language.
-
AI doctor on your phone aims to keep heart patients healthier
Disease control Recruiting nowThis study is testing whether a smartphone app called a 'Smart Family Doctor,' which uses artificial intelligence, can help people better manage their health after heart procedures. It will involve over 500 adults who have had heart surgery or stents and also have high blood pres…
Phase: NA • Sponsor: China National Center for Cardiovascular Diseases • Aim: Disease control
Last updated Apr 02, 2026 02:12 UTC
-
Heart surgery blood thinner trial seeks to prevent graft failures
Disease control Recruiting nowThis study aims to find the best blood-thinning medication combination for patients who have undergone a complex heart bypass surgery called coronary endarterectomy combined with CABG. Researchers will compare two drug regimens to see which one better keeps the new bypass grafts …
Phase: PHASE4 • Sponsor: China National Center for Cardiovascular Diseases • Aim: Disease control
Last updated Apr 01, 2026 14:43 UTC
-
New heart drug trial aims to ease strain for patients with thickened heart muscle
Disease control Recruiting nowThis study is testing whether a medication called ademetionine can help people with obstructive hypertrophic cardiomyopathy (oHCM), a condition where the heart muscle thickens and makes it harder to pump blood. About 44 participants will be randomly assigned to receive either the…
Phase: PHASE2 • Sponsor: China National Center for Cardiovascular Diseases • Aim: Disease control
Last updated Apr 01, 2026 14:42 UTC
-
AI Doctors' assistants tested to tame high blood pressure
Disease control Recruiting nowThis study is testing two different computer decision-support systems to see if they help primary care doctors choose more effective blood pressure medication plans. Over 2,000 adults with high blood pressure across 51 clinics will participate. The computer systems use either sta…
Phase: NA • Sponsor: China National Center for Cardiovascular Diseases • Aim: Disease control
Last updated Mar 31, 2026 12:12 UTC
-
Big brother for blood pressure: computer system tracks 700 PH patients for drug safety
Disease control Recruiting nowThis nationwide study aims to monitor the safety of targeted medications used to treat pulmonary hypertension. Researchers will follow 700 patients every six months using a computerized tracking system to record any side effects and track survival rates. The goal is to better und…
Sponsor: China National Center for Cardiovascular Diseases • Aim: Disease control
Last updated Mar 31, 2026 12:12 UTC
-
Herbal capsule trial aims to tame heart disease inflammation
Disease control Recruiting nowThis study is testing whether Xuesaitong soft capsules, a traditional Chinese medicine, can help control risk factors in people with stable coronary heart disease. It will involve 240 patients who will take either the capsules or a placebo for 12 weeks. Researchers will measure c…
Phase: PHASE4 • Sponsor: China National Center for Cardiovascular Diseases • Aim: Disease control
Last updated Mar 31, 2026 12:11 UTC
-
Heart drug trial offers hope for deadly lung condition
Disease control Recruiting nowThis early-stage study is testing if empagliflozin, a medication typically used for diabetes and heart failure, can help control pulmonary arterial hypertension (PAH)—a serious condition causing high blood pressure in the lungs. The trial will involve 72 adults with PAH who will …
Phase: PHASE1 • Sponsor: China National Center for Cardiovascular Diseases • Aim: Disease control
Last updated Mar 30, 2026 14:34 UTC
-
Your phone as a heart coach: AI tested for home recovery
Disease control Recruiting nowThis study is testing whether a smartphone app and wearable device, powered by artificial intelligence, can safely and effectively guide home exercise for adults with stable coronary heart disease. Researchers want to see if this AI platform helps people get fitter, stay more act…
Phase: NA • Sponsor: China National Center for Cardiovascular Diseases • Aim: Disease control
Last updated Mar 27, 2026 12:39 UTC
-
Can your phone prescribe exercise to fight common health risks?
Disease control Recruiting nowThis study is testing whether a smartphone app that gives personalized exercise advice can help people with common health conditions like high blood pressure or high blood sugar become more physically active. About 100 adults in China who are not currently active will use the app…
Phase: NA • Sponsor: China National Center for Cardiovascular Diseases • Aim: Disease control
Last updated Mar 25, 2026 14:08 UTC
-
AI vs. heart attacks: can your phone save your life?
Disease control Recruiting nowThis study is testing whether a smartphone app powered by artificial intelligence (AI) can help young adults (18-45) who have had early heart disease stay healthier after leaving the hospital. Researchers want to see if the app, which provides reminders, tracks health data, and o…
Phase: NA • Sponsor: China National Center for Cardiovascular Diseases • Aim: Disease control
Last updated Mar 23, 2026 15:19 UTC
-
New hope to stop heart failure before it starts
Disease control Recruiting nowThis study is testing if a drug called empagliflozin can help prevent heart failure in people who have high blood pressure and are at high risk for heart problems, but do not have diabetes. About 120 participants will be randomly assigned to take either the drug or a placebo pill…
Phase: PHASE4 • Sponsor: China National Center for Cardiovascular Diseases • Aim: Disease control
Last updated Mar 20, 2026 14:48 UTC
-
New heart scan could replace uncomfortable artery test
Diagnosis Recruiting nowThis study is testing a new technology that uses ultrasound imaging inside heart arteries to quickly measure if a narrowing is serious enough to need a stent. It aims to see if this new method is as accurate as the current standard test, which requires extra wires and medication …
Phase: NA • Sponsor: China National Center for Cardiovascular Diseases • Aim: Diagnosis
Last updated Mar 27, 2026 12:40 UTC
-
Could a simple photo help spot hidden heart disease? AI study aims to find out
Diagnosis Recruiting nowThis study is testing whether a new artificial intelligence (AI) tool can help find hidden coronary artery disease by analyzing a person's facial photo. It will enroll about 1,400 adults who are at higher risk for heart disease due to diabetes, high blood pressure, or being over …
Sponsor: China National Center for Cardiovascular Diseases • Aim: Diagnosis
Last updated Mar 25, 2026 14:08 UTC
-
Ancient herbs tested to soothe elderly heart pain
Symptom relief Recruiting nowThis study is testing whether two traditional Chinese herbal pills, when added to standard heart medications, can better reduce chest pain and improve daily life for elderly patients with coronary artery disease. It will enroll 120 participants aged 75-90 who still have symptoms …
Phase: PHASE4 • Sponsor: China National Center for Cardiovascular Diseases • Aim: Symptom relief
Last updated Mar 27, 2026 12:40 UTC
-
Doctors test new heart scan to predict Who's at risk
Knowledge-focused Recruiting nowThis study is testing whether a new type of ultrasound measurement taken inside the heart's arteries can help predict which patients with coronary artery disease might have serious heart problems within a year. Researchers will enroll 494 patients who have blockages in all three …
Sponsor: China National Center for Cardiovascular Diseases • Aim: Knowledge-focused
Last updated Mar 27, 2026 12:41 UTC
-
Robot judges surgeons in heart surgery study
Knowledge-focused Recruiting nowThis study is testing whether artificial intelligence (AI) can reliably evaluate how skilled heart surgeons are during bypass surgery. Researchers will compare the AI's assessment scores to scores given by human surgical experts. The goal is to see if AI could become a useful too…
Sponsor: China National Center for Cardiovascular Diseases • Aim: Knowledge-focused
Last updated Mar 27, 2026 12:38 UTC